dihydrocytochalasin b has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
dihydrocytochalasin B: inhibits cell motility in many eucaryotic cells
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehta, P | 1 |
| Zingde, S | 1 |
| Advani, S | 1 |
| Desai, H | 1 |
| Gothoskar, B | 1 |
1 other study available for dihydrocytochalasin b and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Protein 1a: a major wheat germ agglutinin binding protein on the surface of human granulocytes associated with the cytoskeleton.
Topics: Antigens, CD; Concanavalin A; Cytochalasin B; Cytoskeleton; Endocytosis; Female; Granulocytes; Human | 1995 |